ProMab Bio

ProMab Biotechnologies is a biotechnology company and contract research organization (CRO/CDMO) specializing in custom antibody development and advanced cell therapies. Founded in 2001 and headquartered in Richmond, California, the company offers a comprehensive suite of services including monoclonal antibody production, recombinant protein expression, and a fully integrated CAR-T/NK cell therapy platform. ProMab maintains an internal pipeline of CAR-T and bispecific antibody candidates targeting various hematological and solid tumor antigens, with several programs having reached clinical stages through investigator-initiated trials and partnerships. Additionally, the company has expanded into mRNA-LNP technology, providing end-to-end solutions from discovery to GMP manufacturing.